Defense Personnel Support Center, 2800 S 20Th Street, Phila PA 19101-8419

65 -- NARKET SURVEY-TO OBTAIN INFORMATION ON SOL SP0200-96-1010 DUE 070596 POC Contact: POC: Francis Tallent, DPSC-mgab-pea This is a Market survey: The following information is provided to assist pharmaceutical manufacturers in using their presentation time at the pharmacoeconomic Center (PEC) effectively. Pharmacological information or data presented previously to the PEC on individual medications is not needed unless significant new information will be presented. Your presentation should tell US why your product(S) are the most COST effective for the Department of Defense. The most appropriate use of time will include: Head-to-head effectiveness studies of competing therapies and combination therapies. Information relating to rates of side effects of your product. Data relating to dropout rates due to side effects and other causes. Patient compliance specifically related to your product or this disease state. Patient outcomes studies. Pharmacoepidemiological information or studies. And /or quality-of-life studies of the diseasestate. Up to one hour is the preferred length of a presentaiton. Due to the total number ofpresentations, each manufacturer will be limited oto one, 1-hour presentation per disease state. The PEC will use the lowest acquisition price available Fora manufacturer'S product as listed on the Federal supply schedule or a distribution and pricing agreement with the Defense Personnel Support Center. The cut-off date for price submissions that will be considered by the PEC will be announced at a later date. Presentations on the treatment of non-insulin dependent (adult onset) diabetes mellitus will be scheduled for 8-31 July 1996. Please call MS. Scott at (210) 2214311 if you would like to schedule a presentation.(0149)

Loren Data Corp. http://www.ld.com (SYN# 0372 19960529\65-0001.SOL)